Dechra Pharmaceutical shares a ‘long-term value hold'
- 207
7 September 2015: Dechra Pharmaceuticals CEO Ian Page says they will continue to see continued growth in the US, a steady increase in presence in the rest of the world and their product portfolio will continue to deliver results. He says they are looking to maintain double-digit underlying earnings growth in FY16. In regards to the share price, he feels it got overheated but has found its natural level, and if they keep delivering growth the share price will look after itself.
IG Markets
Welcome to the official IG UK YouTube channel. Here you will find everything you need to become a successful trader. Learn more about IG's products, the economy, financial markets, and company insights.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 70% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money. Professional clients can lose more than they deposit
Learn more about IG: https://upl.inc/the-world-of-ig
